Genetic and Environmental Risk Factors for Hemorrhagic Stroke

Part of paid clinical trials in Chicago, Illinois.

Sponsor
State University of New York at Buffalo
Study ID
NCT00682695
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this study is to find risk factors for hemorrhagic stroke.

Key Dates

Start date
Jan 1, 2025
Status verified
Jul 2025
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: 1
    Participants who have had a hemorrhagic stroke at University of Maryland, University of Cincinnati, Massachusetts General Hospital, Duke University, Columbia University and University of Chicago Illinois, age 18 years or greater. Ability of the patient or legal representative to provide informed consent. Racial/ethnic category meets one of the following: African American, Caucasian or Hispanic. Healthy volunteers who are matched to the study cases with hemorrhagic stroke within +/- 5 years of age, same gender and same race.

Primary Outcome Measure

Perform deep DNA sequencing of Chr 1q22 [ Time Frame: Ongoing to be completed at the end of June 2021 ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
University of Illinois ChicagoChicagoIllinois60612
Maureen Hillman
312-355-3863
Fernando Testai, M.D. (PRINCIPAL_INVESTIGATOR)
Baptist Health LouisvilleLouisvilleKentucky40207
Karin Cryan
502-259-5564
Ranjit Bagga, MD (PRINCIPAL_INVESTIGATOR)
University of MarylandBaltimoreMaryland21201
Tiffany Watson
410-706-1902
Steven Kittner, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Christina Kourkoulis
617-726-5358
Jonathan R, MD (PRINCIPAL_INVESTIGATOR)
Columbia UniversityNew YorkNew York10032
Angela Velazquez
212-305-6071
David Roh, M.D. (PRINCIPAL_INVESTIGATOR)
Duke UniversityDurhamNorth Carolina27710
Andreea Podgoreanu
919-681-4054
Michael L James, MD (PRINCIPAL_INVESTIGATOR)
University of CincinnatiCincinnatiOhio45267
Lee A Gilkerson, RN, BSN
513-558-6140
Daniel Woo, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By condition

Related Studies